Abstract:
An image forming apparatus includes a photoreceptor drum, a charging part, an exposure unit, a developing part which feeds a photoreactive toner, a color formation exposure part, a transfer part, a recording medium feeding part, a fixing part, and a control unit part 700 which controls operations of the above elements. The control unit part controls such that a photoreactive toner processed so as not to develop a color is transferred to a recording medium having transferred or fixed thereto a toner image processed so as to develop a color, and a photoreactive toner processed so as not to develop a color is fixed to an image formed on the recording medium, thereby forming a transparent toner coat layer which is a colorless and transparent toner layer.
Abstract:
An image pickup apparatus includes a solid-state image pickup device chip, an FPC whose terminals are connected to the solid-state image pickup device chip, and a plurality of electronic components mounted on a front surface of the FPC, wherein behind a back face of the solid-state image pickup chip, the FPC is disposed by being folded in such a way that the FPC will provide mounting surfaces for the plurality of electronic components in a plurality of layers and that the plurality of electronic components will be superimposed via the FPC.
Abstract:
An image processing apparatus includes: an input section which inputs image data; a memory section which memorizes non-volatily various data including image data inputted by the input section; a cache memory; a control section which carries out an asynchronous operation which writes data to the cache memory in stead of writing to the memory section as well as carries out a sync processing which transfers and stores the data of the cache memory to the memory section based on a predetermined condition; and a detecting section which detects a preparation for carrying out a shut down operation of a power of the image processing apparatus, wherein the control section carries out the sync processing in case when the preparation operation is detected by the detecting section.
Abstract:
A treatment for tumorous canines and a method of preparing, cultivating, and cryogenically preserving the pharmaceutical formulation used in the treatment. Canine lymphocytes are activated and expanded in the presence of a combination of anti-canine CD3 antibodies and interleukin-2 (IL-2) (preferably anti-canine CD3 antibodies and human interleukin-2 (human IL-2)) and administered to tumorous dogs. Following treatment, the canine tumors were observed to be in regression while no serious side effects were noted. Quality-of-life improvements were observed in the form of the animals' ability to walk increased distances and improved coat appearance.